With fewer than 1 in 4 patients with cirrhosis surveilled for HCC, the American Gastroenterological Association (AGA) has ...

Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ...

Perioperative immunotherapy improves hepatocellular carcinoma outcomes, reducing recurrence risk and enhancing event free ...

A new update from the (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma ...

Most liver cancers are preventable, yet cases are rising worldwide due to viral hepatitis, alcohol use, and metabolic liver disease. Experts say targeted prevention, including vaccination, screening, ...

Lebanon baseball's 7-2 win over Kings Thursday was about more than baseball as the Warriors honored senior Zach Amburgy, ...

Most patients were male (85.3%), with a median age of 72 years. Liver cirrhosis was present in 70.6%, and 77% had Barcelona Clinic Liver Cancer stage C. Immunotherapy was predominantly first-line ...

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma The Oncology Grand Rounds series is ...

Primary hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality worldwide, with curative ...

Rznomics announced today that it presented interim clinical data from its ongoing study of RZ-001, an RNA editing-based investigational anticancer therapy, in patients with hepatocellular carcinoma ...